• 1
    Kumashi P,Girgawy E,Tarrand JJ, et al. Streptococcus pneumoniae bacteremia in patients with cancer: disease characteristics and outcomes in the era of escalating drug resistance (1998–2002). Medicine (Baltimore). 2005; 84: 303312.
  • 2
    Stevenson FK,Caligaris-Cappio F. Chronic lymphocytic leukemia: revelations from the B-cell receptors. Blood. 2004; 103: 43894395.
  • 3
    Sklenar I,Schiffman G,Jonsson V, et al. Effect of various doses of intravenous polyclonal IgG on in vivo levels of 12 pneumococcal antibodies in patients with chronic lymphocytic leukemia and multiple myeloma. Oncology. 1993; 50: 466477.
  • 4
    Sinisalo M,Aittoniemi J,Oivanen P, et al. Response to vaccination against different types of antigens in patients with chronic lymphocytic leukemia. Br J Haematol. 2001; 114: 107110.
  • 5
    Musher DM,Rueda-Jaimes AM,Graviss EA, et al. Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia. Clin Infect Dis. 2006; 43: 10041008.
  • 6
    Chang DZ,Lomazow W,Joy Somberg C, et al. Granulocyte-macrophage colony stimulating factor: an adjuvant for cancer vaccines. Hematology. 2004; 9: 207215.
  • 7
    Rezvany MR,Jeddi-Tehrani M,Biberfeld P, et al. Dendritic cells in patients with non-progressive B-chronic lymphocytic leukemia have a normal functional capability but abnormal cytokine pattern. Br J Haematol. 2001; 115: 263271.
  • 8
    Vuillier F,Maloum K,Thomas EK, et al. Functional monocyte-derived dendritic cells can be generated in chronic lymphocytic leukemia. Br J Haematol. 2001; 115: 831844.
  • 9
    Till KJ,Burthem J,Lopez A,Cawley JC. Granulocyte-macrophage colony-stimulating factor receptor: stage-specific expression and function on late B cells. Blood. 1996; 88: 479486.
  • 10
    Wierda WG,O'Brien S,Wang X, et al. Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia. Blood. 2007; 109: 46794685.
  • 11
    Ramanathan RK,Potter DM,Belani CP, et al. Randomized trial of influenza vaccine with granulocyte-macrophage colony-stimulating factor or placebo in cancer patients. J Clin Oncol. 2002; 20: 43134338.
  • 12
    Pauksen K,Linda A,Hammarstrom V, et al. Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients. Clin Infect Dis. 2000; 30: 342348.
  • 13
    Hartkamp A,Mulder AHL,Rijkers GT, et al. Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukemia. Vaccine. 2001; 19: 16711677.
  • 14
    Safdar A,Alma Rodriguez M,Fayad LE, et al. Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin's lymphoma. J Infect Dis. 2006; 194: 13941397.
  • 15
    Chan CY,Molrine DC,George S, et al. Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment with Hodgkin's disease. J Infect Dis. 1996; 173: 256258.